Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Detection of Gross Error: The Q Test01:00

Detection of Gross Error: The Q Test

When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative evaluation of the Mayo Clinic Florida microdosimetric kinetic model and mMKM for carbon ion treatment planning: A matRad-based analysis.

Journal of applied clinical medical physics·2026
Same author

A feasibility study on a machine-learning-based quality assurance tool for spot-scanning proton therapy using delivery log files and treatment plans.

Physics and imaging in radiation oncology·2026
Same author

Computed Tomography Simulation for Gamma Knife Radiosurgery: Impact on Target Coverage.

Journal of medical physics·2026
Same author

Simulation and optimization of treatment schedule for multi-gantry heavy ion therapy.

Technical innovations & patient support in radiation oncology·2026
Same author

Introducing an innovative IMPT algorithm toward clinic implementation of the MCF MKM RBE model for carbon ion therapy.

Medical physics·2025
Same author

Optimizing dose rate to minimize delivery time in proton pencil beam dose-driven continuous scanning.

Medical physics·2025

Related Experiment Video

Updated: May 16, 2026

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
06:33

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

A statistical approach to IMRT patient-specific QA.

Geethpriya Palaniswaamy1, Ryan Scott Brame, Sridhar Yaddanapudi

  • 1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA. gpalaniswaamy@sw.org

Medical Physics
|December 13, 2012
PubMed
Summary

Implementing site-specific quality assurance (QA) tolerances for intensity modulated radiation therapy (IMRT) reduces errors and improves efficiency. Statistical analysis reveals significant differences between treatment sites, necessitating tailored QA protocols for accurate patient treatment.

More Related Videos

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Related Experiment Videos

Last Updated: May 16, 2026

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
06:33

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement

Published on: July 29, 2013

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Statistical Quality Control

Background:

  • Intensity modulated radiation therapy (IMRT) patient-specific quality assurance (QA) is resource-intensive.
  • A single global QA tolerance may lead to excessive false negatives or positives across diverse treatment sites.
  • This can result in wasted resources, treatment delays, and compromised efficiency.

Purpose of the Study:

  • To develop a tool for identifying statistical variations, monitoring trends, and detecting outliers in IMRT QA.
  • To analyze IMRT QA data to understand site-specific differences and evaluate the need for tailored tolerance levels.
  • To reduce false negatives and false positives in QA measurements.

Main Methods:

  • Analysis of QA measurements using two ion chamber points.
  • Development of a custom software tool for data processing, retrieval, visualization, and statistical analysis.
  • Application of analysis of variance (ANOVA) and statistical process control (SPC) techniques.

Main Results:

  • Retrospective analysis confirmed significant differences between treatment sites, supporting the need for site-specific QA tolerances.
  • The developed tool effectively monitored QA process variability using I, S, and exponentially weighted moving average (EWMA) charts.
  • Site-specific tolerances were identified as crucial for reducing false positive and false negative QA results.

Conclusions:

  • Analysis of variance on ion chamber measurements supports the need for site-specific QA tolerances in IMRT.
  • A method for calculating appropriate site-specific tolerances was proposed and illustrated for clinical use.
  • The developed automated tool aids in reducing process variability and uncertainty during IMRT commissioning.